DIY Cancer Treatment
-
https://www.nature.com/articles/d41586-024-03647-0
Beata Halassy discovered in 2020, aged 49, that she had breast cancer at the site of a previous mastectomy. It was the second recurrence there since her left breast had been removed, and she couldn’t face another bout of chemotherapy.
Halassy, a virologist at the University of Zagreb, studied the literature and decided to take matters into her own hands with an unproven treatment.
A case report published in Vaccines in August1 outlines how Halassy self-administered a treatment called oncolytic virotherapy (OVT) to help treat her own stage 3 cancer. She has now been cancer-free for four years.
In choosing to self-experiment, Halassy joins a long line of scientists who have participated in this under-the-radar, stigmatized and ethically fraught practice. “It took a brave editor to publish the report,” says Halassy.
OVT is an emerging field of cancer treatment that uses viruses to both attack cancerous cells and provoke the immune system into fighting them. Most OVT clinical trials so far have been in late-stage, metastatic cancer, but in the past few years they have been directed towards earlier-stage disease. One OVT, called T-VEC, has been in approved in the United States to treat metastatic melanoma, but there are as yet no OVT agents approved to treat breast cancer of any stage, anywhere in the world.
Halassy stresses that she isn’t a specialist in OVT, but her expertise in cultivating and purifying viruses in the laboratory gave her the confidence to try the treatment. She chose to target her tumour with two different viruses consecutively — a measles virus followed by a vesicular stomatitis virus (VSV). Both pathogens are known to infect the type of cell from which her tumour originated, and have already been used in OVT clinical trials. A measles virus has been trialled against metastatic breast cancer.
-
Progress in Medicine tends to occur as a breakthrough and then refinement, IMO.
Looks like we have a breakthrough. Time for refinement and some major clinical trials
